| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.4M | — | -18.0% |
| R&D Expense | $7K | — | +0.0% |
| SG&A Expense | $2.1M | — | -6.7% |
| Operating Income | -$2.5M | — | -10.4% |
| Pre-tax Income | -$3.2M | — | -3.7% |
| Net Income | -$3.2M | — | -3.7% |
| EPS (Basic) | -$0.13 | — | +38.1% |
| EPS (Diluted) | -$0.13 | — | +38.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $201K | +51.1% | -72.4% |
| Accounts Receivable | $738K | +5.9% | +100.5% |
| Current Assets | $10.4M | +0.9% | -18.9% |
| Total Assets | $10.9M | +0.1% | -20.4% |
| Current Liabilities | $27.1M | +5.7% | +37.1% |
| Long-term Debt | $19.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$477K | — | -314.8% |
| Investing Cash Flow | $500K | — | +0.0% |
| Financing Cash Flow | $160K | — | -91.5% |
| +10.1% |
| Total Liabilities | $46.2M | +6.2% | +5.1% |
| Stockholders' Equity | -$35.2M | -8.2% | -16.7% |